Clinical Trials Browser

Phase 1/2 × Recruiting × Other solid neoplasm × Clear all

NCT05101070 2026-03-18

aCCeleR8-001

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT05689853 2026-03-18

Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT06736704 2026-03-13

SNV4818 in Participants With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT07300943 2026-03-13

Study in Advanced Solid Tumor Patients

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT07229638 2026-03-12

A IB/II Phase Clinical Study on the Safety, Tolerability, and Efficacy of SHR-9839(sc) in Combination Anti-tumor Therapy in Patients With Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT07466160 2026-03-12

A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT04939610 2026-03-11

LuMIERE

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT07417189 2026-03-11

A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 )

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors, Adult

NCT06499350 2026-03-10

A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Malignant Solid Tumors

NCT07069062 2026-03-09

A Phase I/Ⅱ Human Study of HY0001a for Injection in Adult Participants With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT06130553 2026-03-06

PRIMROSE

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumors That Are MTAP Deficient

NCT06656390 2026-03-06

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Cancer

NCT06795412 2026-03-06

Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumours

NCT06667960 2026-03-05

Study of JK06 in Patients With Unresectable Locally Advanced or Metastatic Cancer

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT04683250 2026-03-03

MARGARET

Phase 1/2 Recruiting

Other solid neoplasmThoracic

RET-altered Non Small Cell Lung Cancer

NCT05579366 2026-03-03

RAINFOL-01

Phase 1/2 Recruiting

BreastGynecologicOther solid neoplasmThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Fallopian Tube Neoplasms, Mesothelioma, Ovarian Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05083481 2026-02-27

A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT06833008 2026-02-27

A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT07441174 2026-02-27

IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors

Phase 1/2 Recruiting

GastrointestinalOther solid neoplasm

Solid Tumor Cancer

NCT04219254 2026-02-25

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT06911827 2026-02-25

A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT06051695 2026-02-20

EVEREST-2

Phase 1/2 Recruiting

GastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Mesothelioma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Colorectal Neoplasms

NCT07160725 2026-02-17

A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumours

NCT07293754 2026-02-17

RaPTR-101

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Malignant Solid Tumor

NCT07415863 2026-02-17

Phase 1/II Clinical Study of SYS6043 in the Treatment of Advanced/Metastatic Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced/Metastatic Solid Tumors

NCT06885281 2026-02-13

A Study of ZL-1310 in Participants With Selected Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT06598371 2026-02-11

A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Select Advanced Solid Tumors

NCT07328217 2026-02-11

A Phase 1/2 Study of GW5282 in Participants With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT07205718 2026-02-06

A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced or Metastatic Solid Tumors

NCT07392736 2026-02-06

A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT07394374 2026-02-06

A Phase 1/2 Study of CG001419 Tablets in Adult Subjects With Locally Advanced or Metastatic Solid Tumours Harbouring NTRK Gene Abnormalities

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors Harboring NTRK Fusion

NCT07359066 2026-02-05

An Open-label, First-in-Human, Dose-Escalation and Dose-Expansion Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPR1020 in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT07382531 2026-02-04

OH2 Injection in Combination With BS006 Injection for Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT05443126 2026-02-03

A Study of EP0031 in Patients With Advanced RET-altered Malignancies

Phase 1/2 Recruiting

Other solid neoplasmThoracic

Advanced Solid Tumor

NCT06697197 2026-02-03

A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT07266428 2026-02-03

A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT04626635 2026-02-02

COMBINE-EGFR-1

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT06974812 2026-01-29

IBI3014 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Unresectable Locally Advanced or Metastatic Solid Tumors

NCT05867420 2026-01-27

A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT07192432 2026-01-27

SENTRY-HER2

Phase 1/2 Recruiting

Other solid neoplasm

HER2 Expressing Solid Tumors

NCT07093970 2026-01-22

A Study of MRG006A in the Treatment of Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT05584670 2026-01-20

A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT06710756 2026-01-16

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Phase 1/2 Recruiting

GastrointestinalGynecologicHead & NeckOther solid neoplasmSarcomaThoracic

Esophageal Neoplasms, Head and Neck Neoplasms, Mesothelioma, Ovarian Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms

NCT06725758 2026-01-15

TEADES

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumours

NCT05023486 2026-01-14

NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies

Phase 1/2 Recruiting

Other solid neoplasm

Advanced or Metastatic Solid Tumor Malignancies

NCT07253116 2026-01-14

A Phase I/II Clinical Study of WJ22096 Tablets in Patients With Advanced Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT06741644 2026-01-09

A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT06265727 2026-01-08

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT07131202 2026-01-08

A Study of FL115 in Combination With a PD-1 Antibody in Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT05584800 2026-01-05

Study of ZGGS18 in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor